ENCORE, INC. – Trademark Portfolio

Entity Type: 03

ENCORE, INC. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REVIVE and IMPO-AID. The owner is based in SARASOTA, FL.

6976 Professional Parkway East

SARASOTA, FL 34240

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ENCORE, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

39
Transportation & Storage (1 filing)

Transport; packaging and storage of goods; travel arrangement

Frequently Asked Questions

How many trademarks does ENCORE, INC. have?

ENCORE, INC. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 6 cancelled.

What trademark classes does ENCORE, INC. file in?

ENCORE, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ENCORE, INC.'s most well-known trademarks?

ENCORE, INC.'s registered trademark portfolio includes well-known marks such as REVIVE and IMPO-AID. These are among 2 currently registered trademarks in the portfolio.

What is ENCORE, INC.'s trademark registration success rate?

ENCORE, INC. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.